Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Zosano Pharma Corporation (ZSAN)

0.5576   0 (0%) 06-26 20:01
Open: 0.5188 Pre. Close: 0.5576
High: 0.635 Low: 0.46
Volume: 1,155,058 Market Cap: 66(M)
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.64 - 0.64 0.64 - 0.64
Low: 0.45 - 0.46 0.46 - 0.46
Close: 0.55 - 0.56 0.56 - 0.56

Technical analysis

as of: 2022-06-24 4:44:28 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.77     One year: 2.53
Support: Support1: 0.46    Support2: 0.38
Resistance: Resistance1: 1.51    Resistance2: 2.17
Pivot: 0.55
Moving Average: MA(5): 0.55     MA(20): 0.78
MA(100): 4.29     MA(250): 15.15
MACD: MACD(12,26): -0.4     Signal(9): -0.5
Stochastic oscillator: %K(14,3): 24.5     %D(3): 16.2
RSI: RSI(14): 20.3
52-week: High: 32.54  Low: 0.46
Average Vol(K): 3-Month: 569 (K)  10-Days: 1,155 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ZSAN ] has closed above bottom band by 49.9%. Bollinger Bands are 99% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 40 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 17 Jun 2022
Short Interest in Zosano Pharma Co. (NASDAQ:ZSAN) Drops By 15.6% - Defense World

Fri, 17 Jun 2022
Zosano Pharma Co. (NASDAQ:ZSAN) Short Interest Update - Defense World

Fri, 03 Jun 2022
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - InvestorPlace

Thu, 02 Jun 2022
Migraine patch developer Zosano Pharma files for bankruptcy - San Francisco Business Times - The Business Journals

Thu, 02 Jun 2022
Zosano Pharma Shares Slide to New Depths After Chapter 11 Filing >ZSAN - MarketWatch

Fri, 13 May 2022
Zosano Pharma (ZSAN) Reports Q1 Net Loss of $33.4M -

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 118 (M)
% Held by Insiders 4.57e+006 (%)
% Held by Institutions 0.1 (%)
Shares Short 275 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -2.978e+007
EPS Est Next Qtl -0.24
EPS Est This Year -0.86
EPS Est Next Year -0.86
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -4
Return on Assets (ttm) 16.8
Return on Equity (ttm) -32.8
Qtrly Rev. Growth 785000
Gross Profit (p.s.) -20.61
Sales Per Share -25.04
EBITDA (p.s.) -7.06397e+006
Qtrly Earnings Growth -0.3
Operating Cash Flow 0 (M)
Levered Free Cash Flow -28 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.03
Price to Cash Flow 5.17

Stock Dividends

Dividend 0
Forward Dividend 382680
Dividend Yield 0%
Dividend Pay Date 2018-01-25
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.